Riverchase Wealth Management’s AbbVie ABBV Stock Holding History

Riverchase Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.24M	Buy	+4,919	New	+$1.06M	0.58%	29

Other funds holding ABBV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

FWCM

Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Riverchase Wealth Management's ABBV Position: Q2 2026 in Review

Riverchase Wealth Management opened a new position in AbbVie (ABBV) in Q2 2026: 4,919 shares worth $1.24M. The stake represents 0.58% of the portfolio and ranks #29 among its holdings.

1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Riverchase Wealth Management held 4,919 shares of AbbVie worth $1.24M as of Q2 2026.
AbbVie was a new Riverchase Wealth Management position in Q2 2026.
AbbVie made up 0.58% of Riverchase Wealth Management's portfolio in Q2 2026, its #29 holding.
1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Riverchase Wealth Management's 13F filing for Q2 2026, filed 20 Jul 2026.